AskBio Acquires BNB and Gene Therapy Now in Parkinson’s Trials

AskBio Acquires BNB and Gene Therapy Now in Parkinson’s Trials

284735

AskBio Acquires BNB and Gene Therapy Now in Parkinson’s Trials

Brain Neurotherapy Bio (BNB) has joined with Asklepios BioPharmaceutical (AskBio), a merger aiming to expand a gene therapy program for progressive neurodegenerative diseases such as Parkinson’s and multiple system atrophy (MSA), a form of atypical parkinsonism. “I’m pleased to welcome the Brain Neurotherapy Bio team to AskBio,” Sheila Mikhail, co-founder and CEO of AskBio, said in a press release. “We are grateful for the collaboration we’ve had with AskBio and are honored to jointly accelerate clinical development…

You must be logged in to read/download the full post.